Hayashi Tetsuji, Arai Masami, Ueno Masashi, Kinoshita Hirokatsu, Tada Yurika, Koizumi Koichi, Miki Yoshio, Yamaguchi Toshiharu, Kato Yo, Utsunomiya Joji, Muto Tetsuichiro, Sugihara Kenichi
Department of Surgical Oncology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Dis Colon Rectum. 2006 Oct;49(10 Suppl):S23-9. doi: 10.1007/s10350-006-0722-z.
Colorectal cancer and gastric cancer are the two most commonly associated malignancies in Japan. We examined mismatch repair deficiency in the tumors of patients with primary colorectal and gastric cancers retrospectively.
In 103 cases and 102 healthy control subjects, surgical specimens of colorectal and gastric cancer underwent immunohistochemical analysis of mismatch repair proteins (hMLH1 and hMSH2) and microsatellite instability testing.
Immunohistochemical and microsatellite instability testing produced similar results. High microsatellite instability in colorectal cancer was found in 23 of 103 cases (23 percent) with colorectal and gastric cancers, and in 8 of 102 healthy control subjects (8 percent). Twelve (12 percent) had mismatch repair deficiency in both colorectal and gastric cancers, and both tumors had loss of the same mismatch repair protein (hMLH1, n = 5; hMSH2, n = 7). They had the first cancer at a younger age, with a higher frequency of familial colorectal cancer than the others. Seventeen had mismatch repair deficiency in either tumor, which showed loss of expression of hMLH1. Multiple cancers and right-sided colon cancers developed more frequently in patients with mismatch repair deficiency.
Patients with both colorectal and gastric cancers are more likely to have phenotypic evidence of hereditary nonpolyposis colorectal cancer than patients with colorectal cancer only. Among patients with double tumors, 12 percent showed a common deficiency in the same mismatch repair protein in both tumors by immunohistochemistry, and they should undergo genetic counseling for germline mutational analysis. Immunohistochemistry was effective in detecting mismatch repair deficiency of colorectal and gastric cancer as well as microsatellite instability testing, and may be more practical to perform phenotypic analysis of tumors because of its cost-effectiveness.
在日本,结直肠癌和胃癌是两种最常伴发的恶性肿瘤。我们对原发性结直肠癌和胃癌患者的肿瘤进行了错配修复缺陷的回顾性研究。
对103例患者的手术标本和102名健康对照者进行结直肠癌和胃癌的错配修复蛋白(hMLH1和hMSH2)免疫组化分析及微卫星不稳定性检测。
免疫组化和微卫星不稳定性检测结果相似。在103例结直肠癌和胃癌患者中,23例(23%)结直肠癌存在高微卫星不稳定性,102名健康对照者中有8例(8%)存在高微卫星不稳定性。12例(12%)患者的结直肠癌和胃癌均有错配修复缺陷,且两种肿瘤均缺失相同的错配修复蛋白(hMLH1,5例;hMSH2,7例)。他们首次患癌的年龄较轻,家族性结直肠癌的发生率高于其他人。17例患者的其中一种肿瘤存在错配修复缺陷,表现为hMLH1表达缺失。错配修复缺陷患者发生多发癌和右半结肠癌的频率更高。
与仅患有结直肠癌的患者相比,同时患有结直肠癌和胃癌的患者更有可能有遗传性非息肉病性结直肠癌的表型证据。在患有双原发肿瘤的患者中,12%的患者经免疫组化显示两种肿瘤均存在相同错配修复蛋白的共同缺陷,这些患者应接受遗传咨询以进行种系突变分析。免疫组化在检测结直肠癌和胃癌的错配修复缺陷以及微卫星不稳定性检测方面均有效,并且由于其成本效益,在进行肿瘤表型分析时可能更实用。